Overdiagnosis in breast cancer screening: The impact of study design and calculations

Elsebeth Lynge*, Anna Belle Beau, Peer Christiansen, My von Euler-Chelpin, Niels Kroman, Sisse Njor, Ilse Vejborg

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    Overdiagnosis in breast cancer screening is an important issue. A recent study from Denmark concluded that one in three breast cancers diagnosed in screening areas in women aged 50–69 years were overdiagnosed. The purpose of this short communication was to disentangle the study's methodology in order to evaluate the soundness of this conclusion. We found that both the use of absolute differences as opposed to ratios; the sole focus on non-advanced tumours and the crude allocation of tumours and person-years by screening history for women aged 70–84 years, all contributed to the very high estimate of overdiagnosis. Screening affects cohorts of screened women. Danish registers allow very accurate mapping of the fate of every woman. We should be past the phase where studies of overdiagnosis are based on the fixed age groups from routine statistics.

    Sider (fra-til)26-29
    Antal sider4
    TidsskriftEuropean Journal of Cancer
    StatusUdgivet - jul. 2017


    Udforsk hvilke forskningsemner 'Overdiagnosis in breast cancer screening: The impact of study design and calculations' indeholder.